Immunic Therapeutics

Investors

Board of Directors

Richard Rudick

Dr. Richard Rudick

Dr. Richard Rudick is a Fellow of the American Academy of Neurology and served on the faculty of the Cleveland Clinic Foundation until 2014. While at the Cleveland Clinic, he was Director of the Mellen Center for Multiple Sclerosis Treatment and Research, Inaugural Chief Clinical Research Officer, Vice-Chair of the Cleveland Clinic Neuroscience Institute, and Co-Director of the city-wide Cleveland Clinical and Translational Science Collaborative. Between 2014 and 2020, Dr. Rudick served at Biogen as Director of the Value-Based Medicine Innovation Hub and Director of the Medical Evidence, Research and Innovation Unit. He has authored over 250 peer-reviewed publications in the neurology space, was Chair of the National Multiple Sclerosis Society Research Program Advisory Committee, and was a member of the Advisory Council to the National Center for Research Resources and the Director’s Council of Councils at the National Institutes of Health.

Dr. Rudick earned his medical degree from Case Western Reserve University School of Medicine, and completed clinical and research training at the University of Rochester.

Dr. Rudick has been a member of Immunic’s Board since April 2023. He serves on the Nominating and Corporate Governance Committee.